Evaluation of overall survival according to myelodysplastic syndrome-specific comorbidity index in a large series of myelodysplastic syndromes

Haematologica

Volumn 96, Issue 10, 2011, Pages

  Breccia, Massimo ^a   Federico, Vincenzo ^a   Loglisci, Giuseppina ^a   Salaroli, Adriano ^a   Serrao, Alessandra ^a   Alimena, Giuliana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Comorbidities; MDS CI; Myelodysplastic syndromes

Indexed keywords

COMORBIDITY; CORRELATION ANALYSIS; CYTOGENETICS; DIABETES MELLITUS; HEART DISEASE; HUMAN; LETTER; MDS SPECIFIC COMORBIDITY INDEX; MEDICAL DECISION MAKING; MORTALITY; MYELODYSPLASTIC SYNDROME; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OVERALL SURVIVAL; PROGNOSIS; RISK ASSESSMENT; WPSS PROGNOSTIC INDEX;

FEMALE; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS;

EID: 80053623211     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.048991     Document Type: Letter

References (4)

1. Della Porta MG, Malcovati L, Strupp C, Ambaglio I, Kuendgen A, Zipperer E, et al. Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome. Haematologica. 2011;96(3):441-449.
2. Cazzola M. Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Haematologica. 2011;96(3):349-352.
3. Breccia M, Federico V, Latagliata R, Mercanti C, D'Elia GM, Cannella L, et al. Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients. Leuk Res. 2011;35(2):159-162.
4. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007;25(33):3503-3510.